Skip to content
BRC

BRADY CORP

BRADY CORP Q3 FY2025 earnings call

May 16, 2025 · fiscal period ended 2025-04

EPS · actual vs est

$1.22 / $1.22Inline +0.0%

Revenue · actual vs est

$382.6M / $385.5MMiss -0.8%
Ask about this call

Summary

Generated 2025-05-16

Management highlights

  • Organic sales grew 1.6%, acquisitions boosted sales by 10.5%, and adjusted earnings per share increased by 11.9% in the third quarter. - The Americas and Asia region saw excellent organic sales growth of 5.4% and adjusted operating income growth of 20.2%. - The Europe and Australia region had organic sales decline of 5.4% but adjusted operating income rose 3.8% due to restructuring to lower costs. - R&D investment increased by over 8% this quarter, with ongoing integration of R&D functions and new product roadmaps including direct part marking technologies. - Acquired Funai's microfluidic business to round out the portfolio for custom part marking. - Discussed global operations and supply chain in relation to tariffs, with most products manufactured in the country of ultimate sale. - Launched the I6100 industrial desktop label printer and HH86 handheld RFID reader.
View in transcript ↓

Segment performance

In the Americas and Asia region, organic sales grew 5.4% with sales of $253.7 million in the third quarter, and adjusted operating income grew by 20.2%. The Europe and Australia region had an organic sales decline of 5.4% with sales of $128.9 million in the third quarter, but adjusted operating income increased by 3.8% due to restructuring actions. Through the first three quarters of 2025, 52% of revenue was generated in the US, 30% in Europe, 8% in Asia, and the remaining 10% in Australia and the rest of the Americas.

View in transcript ↓

Guidance

  • Adjusted diluted EPS guidance range was tightened from $4.45 - $4.70 per share to $4.48 - $4.63 per share for the fourth quarter. - Organic sales growth is expected to be in the low single-digit percentages for the year ending July 31, 2025. - Depreciation and amortization expense is approximately $40 million, capital expenditures are approximately $25 million, and the full-year income tax rate is approximately 20%. - Risks to guidance include strengthening of the US dollar, inflationary pressures, continued changes in tariffs, and overall slowdown in economic activity.
View in transcript ↓

Risks

  • Strengthening of the US dollar. - Inflationary pressures. - Continued changes in tariffs or other downstream impacts of global trade disruption. - Overall slowdown in economic activity.
View in transcript ↓

Q&A highlights

Q: In terms of the tariff, can you provide color on potential impact on top line, demand destruction or additional revenue from manufacturing moves?

A: No demand destruction seen yet, both Brady and industrial companies carry inventory so haven't seen full effect of tariffs yet, and price increases are likely as tariffs continue.

Q: How sustainable are adjusted SG&A actions?

A: Brady has a long-term journey to drive down SG&A and will continue to look for operational efficiency, with some noise in data points but goal is to continue driving down SG&A.

Q: Walk through acquisition of Funai's microfluidic business?

A: Funai makes industrial inkjet cartridges, integrated with Brady's inkjet printer, providing an opportunity for growth in custom part marking.

Q: About 4Q guide, why opposite directions in Americas and Asia vs Europe?

A: Anticipate headwinds in Americas due to tariffs, expecting moderate recovery in Europe.

Q: Impact of WPS on Europe and Americas?

A: WPS factor is minor in Americas, strong in Europe except UK, with industrial production declines in Germany affecting Europe.

Q: Break out $3.9 million facility closure and reorg cost to segments?

A: Reorg costs are split evenly between regions.

Q: Guess on acquisition's revenue contribution?

A: Estimating first-year sales within $15 - $20 million.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.22$1.22+0.0%$1.09
Revenue$382.6M$385.5M-0.8%$343.4M

Transcript

May 16, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.